This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markine-Goriaynoff, D.
Right arrow Articles by Coutelier, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markine-Goriaynoff, D.
Right arrow Articles by Coutelier, J.-P.

 Previous Article  |  Next Article 

Journal of Virology, January 2002, p. 432-435, Vol. 76, No. 1
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.1.432-435.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch Mutants

Dominique Markine-Goriaynoff{dagger}, and Jean-Paul Coutelier*

Unit of Experimental Medicine, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, 1200 Brussels, Belgium

Received 17 July 2001/ Accepted 2 October 2001

Immunoglobulin G1 (IgG1), IgG2a, and IgG2b switch variants were derived from an IgG3 monoclonal antibody directed against the VP3 envelope glycoprotein of lactate dehydrogenase-elevating virus (LDV). Among the four antibodies, IgG2a delayed the onset and progression of LDV-induced polioencephalomyelitis more than did the other subclasses. This suggests that the IgG2a predominance observed in many IgG antibody responses elicited by live viruses could, at least under some circumstances, correspond to the selection of the best protection for the infected host.

* Corresponding author. Mailing address: Unit of Experimental Medicine, UCL MEXP 7430, Av. Hippocrate 74, B-1200 Brussels, Belgium. Phone: 32 2 764 7437. Fax: 32 2 764 7430. E-mail: coutelier{at}mexp.ucl.ac.be.

{dagger} Present address: 73 Av. Odon Warland, 1030 Brussels, Belgium.

Journal of Virology, January 2002, p. 432-435, Vol. 76, No. 1
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.1.432-435.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Albert, H., Collin, M., Dudziak, D., Ravetch, J. V., Nimmerjahn, F. (2008). In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc. Natl. Acad. Sci. USA 105: 15005-15009 [Abstract] [Full Text]  
  • Broos, K., Janssens, M. E., De Goeyse, I., Vanlandschoot, P., Leroux-Roels, G., Geysen, D., Guisez, Y. (2008). Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit. CVI 15: 852-858 [Abstract] [Full Text]  
  • Kaneko, Y., Nimmerjahn, F., Madaio, M. P., Ravetch, J. V. (2006). Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. JEM 203: 789-797 [Abstract] [Full Text]  
  • Hamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., Tedder, T. F. (2006). Antibody isotype-specific engagement of Fc{gamma} receptors regulates B lymphocyte depletion during CD20 immunotherapy. JEM 203: 743-753 [Abstract] [Full Text]  
  • Nimmerjahn, F., Ravetch, J. V. (2005). Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding. Science 310: 1510-1512 [Abstract] [Full Text]  
  • Gros, L., Dreja, H., Fiser, A. L., Plays, M., Pelegrin, M., Piechaczyk, M. (2005). Induction of Long-Term Protective Antiviral Endogenous Immune Response by Short Neutralizing Monoclonal Antibody Treatment. J. Virol. 79: 6272-6280 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»